Seminars in Nephrology
Volume 26, Issue 2 , Pages 118-133 , March 2006

Epidemiology of Dialysis Patients and Heart Failure Patients

References 

  1. United States Renal Data System . Excerpts from the USRDS 2004 annual data report . Am J Kidney Dis . 2005;45(suppl 1):S1–S280
  2. United States Renal Data System . USRDS 2001 Annual Data Report; Atlas of End Stage Renal Diseases in the United States . Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 2001;
  3. United States Renal Data System . USRDS 2003 Annual Data Report; Atlas of End Stage Renal Diseases in the United States . Bethesda, MD: National Institute of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 2003;
  4. The United States Renal Data System 2002 Annual Data Report . Bethesda: US Department of Public Health and Human Services, Public Health Service, National Institutes of Health; 2002;
  5. Morbidity and mortality of dialysis . NIH Consens Statement . 1993;11:1–33
  6. Symonds T , Berzon R , Marquis P , et al.   Clinical Significance Consensus Meeting G. The clinical significance of quality-of-life results: Practical considerations for specific audiences . Mayo Clin Proc . 2002;77:572–583
  7. Kalantar-Zadeh K , Kilpatrick RD , Kuwae N , et al.   Reverse epidemiology (A spurious hypothesis or a hardcore reality?) . Blood Purif . 2005;23:57–63
  8. Suliman ME , Stenvinkel P , Qureshi AR , et al.   Hyperhomocysteinemia in relation to plasma free amino acids, biomarkers of inflammation and mortality in patients with chronic kidney disease starting dialysis therapy . Am J Kidney Dis . 2004;44:455–465
  9. National Kidney Foundation I . Kidney-Dialysis Outcome Quality Initiative (K/DOQI clinical practice guidelines for cardiovascular disease in dialysis patients) . Am J Kidney Dis . 2005;45(suppl 1):
  10. Wanner C , Krane V , Marz W , et al.   Randomized controlled trial on the efficacy and safety of atorvastatin in patients with type 2 diabetes on hemodialysis (4D study) (Demographic and baseline characteristics) . Kidney Blood Press Res . 2004;27:259–266
  11. Wanner C , Krane V , Marz W , et al.   Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis . N Engl J Med . 2005;353:238–248
  12. Wrone EM , Hornberger JM , Zehnder JL , et al.   Randomized trial of folic acid for prevention of cardiovascular events in end-stage renal disease . J Am Soc Nephrol . 2004;15:420–426
  13. Eknoyan G , Beck GJ , Cheung AK , et al.   Effect of dialysis dose and membrane flux in maintenance hemodialysis . N Engl J Med . 2002;347:2010–2019
  14. Paniagua R , Amato D , Vonesh E , et al.   Effects of increased peritoneal clearances on mortality rates in peritoneal dialysis (ADEMEX, a prospective, randomized, controlled trial) . J Am Soc Nephrol . 2002;13:1307–1320
  15. Kalantar-Zadeh K , Kilpatrick RD , McAllister CJ , et al.   Reverse epidemiology of hypertension and cardiovascular death in the hemodialysis population (The 58th annual fall conference and scientific sessions) . Hypertension . 2005;45:811–817
  16. Agarwal R . Hypertension and survival in chronic hemodialysis patients—past lessons and future opportunities . Kidney Int . 2005;67:1–13
  17. Kalantar-Zadeh K , Kilpatrick RD , Kopple JD . Reverse epidemiology of blood pressure in dialysis patients . Kidney Int . 2005;67:2067–2068
  18. Kalantar-Zadeh K , Block G , Humphreys MH , et al.   Reverse epidemiology of cardiovascular risk factors in maintenance dialysis patients . Kidney Int . 2003;63:793–808
  19. Nishizawa Y , Shoji T , Ishimura E , et al.   Paradox of risk factors for cardiovascular mortality in uremia (Is a higher cholesterol level better for atherosclerosis in uremia?) . Am J Kidney Dis . 2001;38:S4–S7
  20. Fleischmann EH , Bower JD , Salahudeen AK . Risk factor paradox in hemodialysis (Better nutrition as a partial explanation) . ASAIO J . 2001;47:74–81
  21. Salahudeen AK . Obesity and survival on dialysis . Am J Kidney Dis . 2003;41:925–932
  22. Kalantar-Zadeh K , Kopple J . Malnutrition as a cause of morbidity and mortality in dialysis patients . In:  Kopple J ,  Massry S editor. Nutritional Management of Renal Disease . (ed 2). Philadelphia: Lippincott, Williams & Wilkins; 2004;
  23. Kopple JD . Nutritional status as a predictor of morbidity and mortality in maintenance dialysis patients . ASAIO J . 1997;43:246–250
  24. Fung F , Sherrard DJ , Gillen DL , et al.   Increased risk for cardiovascular mortality among malnourished end-stage renal disease patients . Am J Kidney Dis . 2002;40:307–314
  25. Kopple JD . The phenomenon of altered risk factor patterns or reverse epidemiology in persons with advanced chronic kidney failure . Am J Clin Nutr . 2005;81:1257–1266
  26. Kalantar-Zadeh K , Block G , Horwich T , et al.   Reverse epidemiology of conventional cardiovascular risk factors in patients with chronic heart failure . J Am Coll Cardiol . 2004;43:1439–1444
  27. Rauchhaus M , Clark AL , Doehner W , et al.   The relationship between cholesterol and survival in patients with chronic heart failure . J Am Coll Cardiol . 2003;42:1933–1940
  28. Stevens J , Cai J , Pamuk ER , et al.   The effect of age on the association between body-mass index and mortality . N Engl J Med . 1998;338:1–7
  29. Yeh S , Wu SY , Levine DM , et al.   Quality of life and stimulation of weight gain after treatment with megestrol acetate (Correlation between cytokine levels and nutritional status, appetite in geriatric patients with wasting syndrome) . J Nutr Health Aging . 2000;4:246–251
  30. Landi F , Onder G , Gambassi G , et al.   Body mass index and mortality among hospitalized patients . Arch Intern Med . 2000;160:2641–2644
  31. Chao FC , Efron B , Wolf P . The possible prognostic usefulness of assessing serum proteins and cholesterol in malignancy . Cancer . 1975;35:1223–1229
  32. Roubenoff R . Acquired immunodeficiency syndrome wasting, functional performance, and quality of life . Am J Manag Care . 2000;6:1003–1016
  33. Wilson DO , Rogers RM , Wright EC , et al.  The National Institutes of Health Intermittent Positive-Pressure Breathing Trial   Body weight in chronic obstructive pulmonary disease . Am Rev Respir Dis . 1989;139:1435–1438
  34. Calle EE , Thun MJ , Petrelli JM , et al.   Body-mass index and mortality in a prospective cohort of U.S. adults . N Engl J Med . 1999;341:1097–1105
  35. Kalantar-Zadeh K , Ikizler TA , Block G , et al.   Malnutrition-inflammation complex syndrome in dialysis patients (Causes and consequences) . Am J Kidney Dis . 2003;42:864–881
  36. Kalantar-Zadeh K , Kopple JD . Relative contributions of nutrition and inflammation to clinical outcome in dialysis patients . Am J Kidney Dis . 2001;38:1343–1350
  37. Bergstrom J . Inflammation, malnutrition, cardiovascular disease and mortality in end-stage renal disease . Pol Arch Med Wewn . 2000;104:641–643
  38. Qureshi AR , Alvestrand A , Divino-Filho JC , et al.   Inflammation, malnutrition, and cardiac disease as predictors of mortality in hemodialysis patients . J Am Soc Nephrol . 2002;13(suppl 1):S28–S36
  39. Stenvinkel P . Malnutrition and chronic inflammation as risk factors for cardiovascular disease in chronic renal failure . Blood Purif . 2001;19:143–151
  40. Stenvinkel P , Chung SH , Heimburger O , et al.   Malnutrition, inflammation, and atherosclerosis in peritoneal dialysis patients . Perit Dial Int . 2001;21(suppl 3):S157–S162
  41. Ifudu O , Uribarri J , Rajwani I , et al.   Low hematocrit may connote a malnutrition-inflammation syndrome in hemodialysis patients . Dial Transplant . 2002;31:845–878
  42. Kalantar-Zadeh K , McAllister CJ , Lehn RS , et al.   Effect of malnutrition-inflammation complex syndrome on EPO hyporesponsiveness in maintenance hemodialysis patients . Am J Kidney Dis . 2003;42:761–773
  43. Kalantar-Zadeh K , Regidor DL , Nissenson AR , et al.   Association between changes in hemoglobin over time and survival in hemodialysis patients . J Am Soc Nephrol . 2005;16:489A; (abstract)
  44. Kalantar-Zadeh K , Regidor DL , Nissenson AR , et al.   Association between changes in hemoglobin over time and survival in hemodialysis patients . J Am Soc Neph . 2005;16:489A; (abstract)
  45. Kopple JD . McCollum Award Lecture, 1996 (Protein-energy malnutrition in maintenance dialysis patients) . Am J Clin Nutr . 1997;65:1544–1557
  46. Kopple JD . Pathophysiology of protein-energy wasting in chronic renal failure . J Nutr . 1999;129:247S–251S
  47. Mehrotra R , Kopple J . Causes of protein-energy malnutrition in chronic renal failure . In:  Kopple J ,  Massry S editor. Nutritional Management of Renal Disease . (ed 2). Philadelphia: Lippincott, Williams & Wilkins; 2003;
  48. Qureshi AR , Alvestrand A , Danielsson A , et al.   Factors predicting malnutrition in hemodialysis patients (A cross-sectional study) . Kidney Int . 1998;53:773–782
  49. Bergstrom J . Why are dialysis patients malnourished? . Am J Kidney Dis . 1995;26:229–241
  50. Kalantar-Zadeh K , Kopple J . Inflammation in renal failure . In:  Rose B editors. UpToDate (since Oct 2002) . Wellesley, MA: UpToDate, Inc; 2003;
  51. Kalantar-Zadeh K , Block G , McAllister CJ , et al.   Appetite and inflammation, nutrition, anemia and clinical outcome in hemodialysis patients . Am J Clin Nutr . 2004;80:299–307
  52. Kalantar-Zadeh K . Recent advances in understanding the malnutrition-inflammation complex syndrome in CKD patients (What is next?) . Semin Dial . 2005;18:365–369 (in press)
  53. Kalantar-Zadeh K , Stenvinkel P , Bross R , et al.   Kidney insufficiency and nutrient-based modulation of inflammation . Curr Opin Clin Nutr Metab Care . 2005;8:388–396
  54. Anker SD , Negassa A , Coats AJ , et al.   Prognostic importance of weight loss in chronic heart failure and the effect of treatment with angiotensin-converting-enzyme inhibitors (An observational study) . Lancet . 2003;361:1077–1083
  55. Anker SD , Chua TP , Ponikowski P , et al.   Hormonal changes and catabolic/anabolic imbalance in chronic heart failure and their importance for cardiac cachexia . Circulation . 1997;96:526–534
  56. Anker SD , Steinborn W , Strassburg S . Cardiac cachexia . Ann Med . 2004;36:518–529
  57. Okonko DO , Crosato M , Kalra PR , et al.   Association of deranged adrenal steroid metabolism with anemia in chronic heart failure . Am J Cardiol . 2005;96:101–103
  58. Horwich TB , Fonarow GC , Hamilton MA , et al.   Anemia is associated with worse symptoms, greater impairment in functional capacity and a significant increase in mortality in patients with advanced heart failure . J Am Coll Cardiol . 2002;39:1780–1786
  59. Sharma R , Francis DP , Pitt B , et al.   Haemoglobin predicts survival in patients with chronic heart failure (A substudy of the ELITE II trial) . Eur Heart J . 2004;25:1021–1028
  60. Kalantar-Zadeh K , Braglia A , Chow J , et al.   An anti-inflammatory and anti-oxidant nutritional supplement for hypoalbuminemic dialysis patients (A pilot/feasibility study) . J Ren Nutr . 2005;15:318–331
  61. Kalantar-Zadeh K . The latest addition to the inflammatory homeboys in chronic kidney disease (Interleukin-8) . Nephron Clin Pract . 2005;102:c59–c60
  62. Rammohan M , Kalantar-Zadeh K , Liang A , et al.   Megestrol acetate in moderate dose for the treatment of malnutrition-inflammation complex in maintenance dialysis patients . J Ren Nutr . 2005;15:345–355
  63. Ridker PM , Rifai N , Rose L , et al.   Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events . N Engl J Med . 2002;347:1557–1565
  64. Ridker PM , Cannon CP , Morrow D , et al.   C-reactive protein levels and outcomes after statin therapy . N Engl J Med . 2005;352:20–28
  65. Stenvinkel P , Ketteler M , Johnson RJ , et al.   IL-10, IL-6, and TNF-alpha (Central factors in the altered cytokine network of uremia—the good, the bad, and the ugly) . Kidney Int . 2005;67:1216–1233
  66. Kalantar-Zadeh K , Kopple JD , Humphreys MH , et al.   Comparing outcome predictability of markers of malnutrition-inflammation complex syndrome in haemodialysis patients . Nephrol Dial Transplant . 2004;19:1507–1519
  67. Panichi V , Taccola D , Manca Rizza J , et al.   Interleukin 8 is a powerful prognostic predictor of all cause and cardiovascular mortality in dialytic patients . Nephron Clin Pract . 2005;102:c51–c58
  68. Rauchhaus M , Doehner W , Francis DP , et al.   Plasma cytokine parameters and mortality in patients with chronic heart failure . Circulation . 2000;102:3060–3067
  69. Stenvinkel P , Barany P , Heimburger O , et al.   Mortality, malnutrition, and atherosclerosis in ESRD (What is the role of interleukin-6?) . Kidney Int . 2002;(suppl 1):103–108
  70. Zimmermann J , Herrlinger S , Pruy A , et al.   Inflammation enhances cardiovascular risk and mortality in hemodialysis patients . Kidney Int . 1999;55:648–658
  71. Bologa RM , Levine DM , Parker TS , et al.   Interleukin-6 predicts hypoalbuminemia, hypocholesterolemia, and mortality in hemodialysis patients . Am J Kidney Dis . 1998;32:107–114
  72. Iseki K , Yamazato M , Tozawa M , et al.   Hypocholesterolemia is a significant predictor of death in a cohort of chronic hemodialysis patients . Kidney Int . 2002;61:1887–1893
  73. Lowrie EG , Lew NL . Death risk in hemodialysis patients (The predictive value of commonly measured variables and an evaluation of death rate differences between facilities) . Am J Kidney Dis . 1990;15:458–482
  74. Habib AN , Baird BC , Leypoldt JK , et al.   The association of lipid levels with mortality in patients on chronic peritoneal dialysis . Am J Kidney Dis . 2005;45:A28; (abstr)
  75. Kilpatrick RD , McAllister CJ , Kalantar-Zadeh K . Comparing mortality-predictability of serum total cholesterol and low density lipoprotein (LDL) cholesterol in hemodialysis patients . J Am Soc Nephrol . 2005;16:728A; (abstract)
  76. Kalantar-Zadeh K , Horwich TB , Fonarow GC , et al.   A low, rather than a high, serum LDL cholesterol is associated with increased mortality in hemodialysis patients even after controlling for inflammation . 37th annual conference of the American Society of Nephrology J Am Soc Nephrol . 2004;15(suppl):173A; (abstr)
  77. Vredevoe DL , Woo MA , Doering LV , et al.   Skin test anergy in advanced heart failure secondary to either ischemic or idiopathic dilated cardiomyopathy . Am J Cardiol . 1998;82:323–328
  78. Richartz BM , Radovancevic B , Frazier OH , et al.   Low serum cholesterol levels predict high perioperative mortality in patients supported by a left-ventricular assist system . Cardiology . 1998;89:184–188
  79. Horwich TB , Hamilton MA , Maclellan WR , et al.   Low serum total cholesterol is associated with marked increase in mortality in advanced heart failure . J Card Fail . 2002;8:216–224
  80. Lissin LW , Gauri AJ , Froelicher VF , et al.   The prognostic value of body mass index and standard exercise testing in male veterans with congestive heart failure . J Card Fail . 2002;8:206–215
  81. Kalantar-Zadeh K , Kilpatrick RD , Kopple JD , et al.   A matched comparison of serum lipids between hemodialysis patients and nondialysis morbid controls . Hemodialysis Int . 2005;9:314–324
  82. Liu Y , Coresh J , Eustace JA , et al.   Association between cholesterol level and mortality in dialysis patients (Role of inflammation and malnutrition) . JAMA . 2004;291:451–459
  83. Kalantar-Zadeh K , Anker SD . Inflammation, cholesterol levels, and risk of mortality among patients receiving dialysis . JAMA . 2004;291:1834–1835
  84. Colhoun HM , Betteridge DJ , Durrington PN , et al.   Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS) (Multicentre randomised placebo-controlled trial) . Lancet . 2004;364:685–696
  85. Rauchhaus M , Koloczek V , Volk H , et al.   Inflammatory cytokines and the possible immunological role for lipoproteins in chronic heart failure . Int J Cardiol . 2000;76:125–133
  86. Rauchhaus M , Coats AJ , Anker SD . The endotoxin-lipoprotein hypothesis . Lancet . 2000;356:930–933
  87. Sharma R , von Haehling S , Rauchhaus M , et al.   Whole blood endotoxin responsiveness in patients with chronic heart failure (The importance of serum lipoproteins) . Eur J Heart Fail . 2005;7:479–484
  88. Kalantar-Zadeh K , Kilpatrick RD , McAllister CJ . Black race modifies the reverse association between low density lipoprotein (LDL) and death risk in hemodialysis patients . J Am Soc Nephrol . 2005;16:295A; (abstr)
  89. Kalantar-Zadeh K , Abbott KC , Salahudeen AK , et al.   Survival advantages of obesity in dialysis patients . Am J Clin Nutr . 2005;81:543–554
  90. Degoulet P , Legrain M , Reach I , et al.   Mortality risk factors in patients treated by chronic hemodialysis. Report of the Diaphane collaborative study . Nephron . 1982;31:103–110
  91. Leavey SF , Strawderman RL , Jones CA , et al.   Simple nutritional indicators as independent predictors of mortality in hemodialysis patients . Am J Kidney Dis . 1998;31:997–1006
  92. Fleischmann E , Teal N , Dudley J , et al.   Influence of excess weight on mortality and hospital stay in 1346 hemodialysis patients . Kidney Int . 1999;55:1560–1567
  93. Kopple JD , Zhu X , Lew NL , et al.   Body weight-for-height relationships predict mortality in maintenance hemodialysis patients . Kidney Int . 1999;56:1136–1148
  94. Wolfe RA , Ashby VB , Daugirdas JT , et al.   Body size, dose of hemodialysis, and mortality . Am J Kidney Dis . 2000;35:80–88
  95. Leavey SF , McCullough K , Hecking E , et al.   Body mass index and mortality in ‘healthier’ as compared with ‘sicker’ haemodialysis patients (Results from the Dialysis Outcomes and Practice Patterns Study (DOPPS)) . Nephrol Dial Transplant . 2001;16:2386–2394
  96. Port FK , Ashby VB , Dhingra RK , et al.   Dialysis dose and body mass index are strongly associated with survival in hemodialysis patients . J Am Soc Nephrol . 2002;13:1061–1066
  97. Lowrie EG , Li Z , Ofsthun N , et al.   Body size, dialysis dose and death risk relationships among hemodialysis patients . Kidney Int . 2002;62:1891–1897
  98. Glanton CW , Hypolite IO , Hshieh PB , et al.   Factors associated with improved short term survival in obese end stage renal disease patients . Ann Epidemiol . 2003;13:136–143
  99. Johansen KL , Young B , Kaysen GA , et al.   Association of body size with outcomes among patients beginning dialysis . Am J Clin Nutr . 2004;80:324–332
  100. Kalantar-Zadeh K , Kopple JD , Kilpatrick RD , et al.   Association of morbid obesity and weight change on cardiovascular survival in hemodialysis population . Am J Kidney Dis . 2005;46:489–500
  101. Beddhu S , Pappas LM , Ramkumar N , et al.   Effects of body size and body composition on survival in hemodialysis patients . J Am Soc Nephrol . 2003;14:2366–2372
  102. Beddhu S , Pappas LM , Ramkumar N , et al.   Body mass index and survival in incident dialysis patients (The answer depends on the question) . Am J Clin Nutr . 2005;81:534–536
  103. Beddhu S , Ramkumar N , Samore MH . The paradox of the BMI paradox in dialysis patients (Associations of adiposity with inflammation) . Am J Clin Nutrition . 2005;82:909–910
  104. Kalantar-Zadeh K , Abbott KC , Salahudeen AK . Reverse epidemiology of obesity in dialysis patients (Fat or muscle (letter)?) . Am J Clin Nutr . 2005; (in press)
  105. Kalantar-Zadeh K , Kuwae K , Wu DY , et al.   Associations of body fat and its changes over time with quality of life and prospective mortality in hemodialysis patients . Am J Clin Nutrition . 2006; (in press)
  106. Kimmel PL , Chawla LS , Amarasinghe A , et al.   Anthropometric measures, cytokines and survival in haemodialysis patients . Nephrol Dial Transplant . 2003;18:326–332
  107. Contaldo F , Pasanisi F , Finelli C , et al.   Obesity, heart failure and sudden death . Nutr Metab Cardiovasc Dis . 2002;12:190–197
  108. Kenchaiah S , Evans JC , Levy D , et al.   Obesity and the risk of heart failure . N Engl J Med . 2002;347:305–313
  109. Pasini E , Aquilani R , Gheorghiade M , et al.   Malnutrition, muscle wasting and cachexia in chronic heart failure (The nutritional approach) . Ital Heart J . 2003;4:232–235
  110. Conraads VM , Bosmans JM , Vrints CJ . Chronic heart failure (An example of a systemic chronic inflammatory disease resulting in cachexia) . Int J Cardiol . 2002;85:33–49
  111. Ajayi AA , Adigun AQ , Ojofeitimi EO , et al.   Anthropometric evaluation of cachexia in chronic congestive heart failure (The role of tricuspid regurgitation) . Int J Cardiol . 1999;71:79–84
  112. Wassertheil-Smoller S , Fann C , Allman RM , et al.  The SHEP Cooperative Research Group   Relation of low body mass to death and stroke in the systolic hypertension in the elderly program . Arch Intern Med . 2000;160:494–500
  113. Horwich TB , Fonarow GC , Hamilton MA , et al.   The relationship between obesity and mortality in patients with heart failure . J Am Coll Cardiol . 2001;38:789–795
  114. Mosterd A , Cost B , Hoes AW , et al.   The prognosis of heart failure in the general population (The Rotterdam Study) . Eur Heart J . 2001;22:1318–1327
  115. Davos CH , Doehner W , Rauchhaus M , et al.   Body mass and survival in patients with chronic heart failure without cachexia (The importance of obesity) . J Card Fail . 2003;9:29–35
  116. Lavie CJ , Osman AF , Milani RV , et al.   Body composition and prognosis in chronic systolic heart failure (The obesity paradox) . Am J Cardiol . 2003;91:891–894
  117. Curtis JP , Selter JG , Wang Y , et al.   The obesity paradox (Body mass index and outcomes in patients with heart failure) . Arch Intern Med . 2005;165:55–61
  118. Gustafsson F , Kragelund CB , Torp-Pedersen C , et al.   Effect of obesity and being overweight on long-term mortality in congestive heart failure (Influence of left ventricular systolic function) . Eur Heart J . 2005;26:58–64
  119. Anker SD , Ponikowski P , Varney S , et al.   Wasting as independent risk factor for mortality in chronic heart failure . Lancet . 1997;349:1050–1053
  120. Salem M . Hypertension in the hemodialysis population? High time for answers . Am J Kidney Dis . 1999;33:592–594
  121. Iseki K , Miyasato F , Tokuyama K , et al.   Low diastolic blood pressure, hypoalbuminemia, and risk of death in a cohort of chronic hemodialysis patients . Kidney Int . 1997;51:1212–1217
  122. Zager PG , Nikolic J , Brown RH , et al.  Medical Directors of Dialysis Clinic, Inc.   “U” curve association of blood pressure and mortality in hemodialysis patients . Kidney Int . 1998;54:561–569
  123. Port FK , Hulbert-Shearon TE , Wolfe RA , et al.   Predialysis blood pressure and mortality risk in a national sample of maintenance hemodialysis patients . Am J Kidney Dis . 1999;33:507–517
  124. Klassen PS , Lowrie EG , Reddan DN , et al.   Association between pulse pressure and mortality in patients undergoing maintenance hemodialysis . JAMA . 2002;287:1548–1555
  125. Lowrie EG , Huang WH , Lew NL , et al.   The relative contribution of measured variables to death risk among hemodialysis patients . In:  E G editors. Death on Hemodialysis . Amsterdam: Kluwer Academic Publishers; 1994;p. 121
  126. Duranti E , Imperiali P , Sasdelli M . Is hypertension a mortality risk factor in dialysis? . Kidney Int Suppl . 1996;55:S173–S174
  127. Salem MM , Bower J . Hypertension in the hemodialysis population (Any relation to one-year survival?) . Am J Kidney Dis . 1996;28:737–740
  128. Foley RN . Cardiac disease in chronic uremia (Can it explain the reverse epidemiology of hypertension and survival in dialysis patients?) . Semin Dial . 2004;17:275–278
  129. Ghali JK , Kadakia S , Bhatt A , et al.   Survival of heart failure patients with preserved versus impaired systolic function (The prognostic implication of blood pressure) . Am Heart J . 1992;123:993–997
  130. Rihal CS , Nishimura RA , Hatle LK , et al.   Systolic and diastolic dysfunction in patients with clinical diagnosis of dilated cardiomyopathy. Relation to symptoms and prognosis . Circulation . 1994;90:2772–2779
  131. Cowie MR , Wood DA , Coats AJ , et al.   Survival of patients with a new diagnosis of heart failure (A population based study) . Heart . 2000;83:505–510
  132. Pulignano G , Del Sindaco D , Tavazzi L , et al.   Clinical features and outcomes of elderly outpatients with heart failure followed up in hospital cardiology units (Data from a large nationwide cardiology database (IN-CHF Registry)) . Am Heart J . 2002;143:45–55
  133. Muntwyler J , Abetel G , Gruner C , et al.   One-year mortality among unselected outpatients with heart failure . Eur Heart J . 2002;23:1861–1866
  134. Poole-Wilson PA , Uretsky BF , Thygesen K , et al.   Mode of death in heart failure (Findings from the ATLAS trial) . Heart . 2003;89:42–48
  135. Nygard O , Nordrehaug JE , Refsum H , et al.   Plasma homocysteine levels and mortality in patients with coronary artery disease . N Engl J Med . 1997;337:230–236
  136. Chauveau P , Chadefaux B , Coude M , et al.   Hyperhomocysteinemia, a risk factor for atherosclerosis in chronic uremic patients . Kidney Int Suppl . 1993;41:S72–S77
  137. Bachmann J , Tepel M , Raidt H , et al.   Hyperhomocysteinemia and the risk for vascular disease in hemodialysis patients . J Am Soc Nephrol . 1995;6:121–125
  138. Robinson K , Gupta A , Dennis V , et al.   Hyperhomocysteinemia confers an independent increased risk of atherosclerosis in end-stage renal disease and is closely linked to plasma folate and pyridoxine concentrations . Circulation . 1996;94:2743–2748
  139. Jungers P , Chauveau P , Bandin O , et al.   Hyperhomocysteinemia is associated with atherosclerotic occlusive arterial accidents in predialysis chronic renal failure patients . Miner Electrolyte Metab . 1997;23:170–173
  140. Bostom AG , Shemin D , Verhoef P , et al.   Elevated fasting total plasma homocysteine levels and cardiovascular disease outcomes in maintenance dialysis patients. A prospective study . Arterioscler Thromb Vasc Biol . 1997;17:2554–2558
  141. Moustapha A , Naso A , Nahlawi M , et al.   Prospective study of hyperhomocysteinemia as an adverse cardiovascular risk factor in end-stage renal disease . Circulation . 1998;97:138–141
  142. Kunz K , Petitjean P , Lisri M , et al.   Cardiovascular morbidity and endothelial dysfunction in chronic haemodialysis patients (Is homocyst(e)ine the missing link?) . Nephrol Dial Transplant . 1999;14:1934–1942
  143. Dierkes J , Domrose U , Westphal S , et al.   Cardiac troponin T predicts mortality in patients with end-stage renal disease . Circulation . 2000;102:1964–1969
  144. Ducloux D , Bresson-Vautrin C , Kribs M , et al.   C-reactive protein and cardiovascular disease in peritoneal dialysis patients . Kidney Int . 2002;62:1417–1422
  145. Mallamaci F , Zoccali C , Tripepi G , et al.   Hyperhomocysteinemia predicts cardiovascular outcomes in hemodialysis patients . Kidney Int . 2002;61:609–614
  146. Kronenberg F , Mundle M , Langle M , et al.   Prevalence and progression of peripheral arterial calcifications in patients with ESRD . Am J Kidney Dis . 2003;41:140–148
  147. Vychytil A , Fodinger M , Wolfl G , et al.   Major determinants of hyperhomocysteinemia in peritoneal dialysis patients . Kidney Int . 1998;53:1775–1782
  148. Bayes B , Pastor MC , Bonal J , et al.   Homocysteine, C-reactive protein, lipid peroxidation and mortality in haemodialysis patients . Nephrol Dial Transplant . 2003;18:106–112
  149. London GM , Pannier B , Agharazii M , et al.   Forearm reactive hyperemia and mortality in end-stage renal disease . Kidney Int . 2004;65:700–704
  150. Sirrs S , Duncan L , Djurdjev O , et al.   Homocyst(e)ine and vascular access complications in haemodialysis patients (Insights into a complex metabolic relationship) . Nephrol Dial Transplant . 1999;14:738–743
  151. Suliman ME , Qureshi AR , Barany P , et al.   Hyperhomocysteinemia, nutritional status, and cardiovascular disease in hemodialysis patients . Kidney Int . 2000;57:1727–1735
  152. Wrone EM , Zehnder JL , Hornberger JM , et al.   An MTHFR variant, homocysteine, and cardiovascular comorbidity in renal disease . Kidney Int . 2001;60:1106–1113
  153. Suliman ME , Stenvinkel P , Heimburger O , et al.   Plasma sulfur amino acids in relation to cardiovascular disease, nutritional status, and diabetes mellitus in patients with chronic renal failure at start of dialysis therapy . Am J Kidney Dis . 2002;40:480–488
  154. Kalantar-Zadeh K , Block G , Humphreys MH , et al.   A low, rather than a high, total plasma homocysteine is an indicator of poor outcome in hemodialysis patients . J Am Soc Nephrol . 2004;15:442–453
  155. Montori VM , Smieja M , Guyatt GH . Publication bias (A brief review for clinicians) . Mayo Clin Proc . 2000;75:1284–1288
  156. Hatamizadeh P , Regidor DL , Kopple JD , et al.   Association between baseline serum creatinine and all-cause and cardiovascular mortality in maintenance hemodialysis patients . J Am Soc Nephrol . 2005; (abstr) (in press)
  157. Combe C , McCullough KP , Asano Y , et al.   Kidney Disease Outcomes Quality Initiative (K/DOQI) and the Dialysis Outcomes and Practice Patterns Study (DOPPS) (Nutrition guidelines, indicators, and practices) . Am J Kidney Dis . 2004;44:39–46
  158. Kalantar-Zadeh K , McAllister CJ , Lehn RS , et al.   A low serum iron level is a predictor of poor outcome in hemodialysis patients . Am J Kidney Dis . 2004;43:671–684
  159. Kalantar-Zadeh K , Regidor DL , McAllister CJ , et al.   Time-dependent associations between iron and mortality in hemodialysis patients . J Am Soc Nephrol . 2005;16:3070–3080
  160. Schwedler SB , Metzger T , Schinzel R , et al.   Advanced glycation end products and mortality in hemodialysis patients . Kidney Int . 2002;62:301–310
  161. Wu DY , Kilpatrick RD , Dadres S , et al.   Association between serum bicarbonate and death in hemodialysis patients (Is it better to be acidotic or alkalotic?) . Hemodialysis Int . 2005;9:110; (abstr)
  162. Kalantar-Zadeh K , Kilpatrick RD , Wu DY , et al.   Association between serum bicarbonate and cardiovascular death in hemodialysis patients . J Am Soc Neph . 2005;16:717A–718A (abstr)
  163. Wu DY , McAllister CJ , Kilpatrick RD , et al.   Association between serum bicarbonate and death in hemodialysis patients (Is it better to be acidotic or alkalotic?) . Clin J Am Soc Neph 1 . 2006; Jan (in press)
  164. Kalantar-Zadeh K , Mehrotra R , Fouque D , et al.   Metabolic acidosis and malnutrition-inflammation complex syndrome in chronic renal failure . Semin Dial . 2004;17:445–465
  165. Ascherio A , Rimm EB , Giovannucci EL , et al.   A prospective study of nutritional factors and hypertension among US men . Circulation . 1992;86:1475–1484
  166. Allender PS , Cutler JA , Follmann D , et al.   Dietary calcium and blood pressure (A meta-analysis of randomized clinical trials) . Ann Intern Med . 1996;124:825–831
  167. Bucher HC , Cook RJ , Guyatt GH , et al.   Effects of dietary calcium supplementation on blood pressure. A meta-analysis of randomized controlled trials . JAMA . 1996;275:1016–1022
  168. Bostick RM , Kushi LH , Wu Y , et al.   Relation of calcium, vitamin D, and dairy food intake to ischemic heart disease mortality among postmenopausal women . Am J Epidemiol . 1999;149:151–161
  169. Tussing L , Chapman-Novakofski K . Osteoporosis prevention education (Behavior theories and calcium intake) . J Am Diet Assoc . 2005;105:92–97
  170. Crooks PW , Coburn JW . Management of bone disease in the dialysis patient . Blood Purif . 1985;3:27–41
  171. Block GA , Klassen PS , Lazarus JM , et al.   Mineral metabolism, mortality, and morbidity in maintenance hemodialysis . J Am Soc Nephrol . 2004;15:2208–2218
  172. Slinin Y , Foley RN , Collins AJ . Calcium, phosphorus, parathyroid hormone, and cardiovascular disease in hemodialysis patients (The USRDS waves 1, 3, and 4 study) . J Am Soc Nephrol . 2005;16:1788–1793
  173. National Kidney Foundation I . Kidney Disease-Dialysis Outcome Quality Initiative (K/DOQI Clinical Practice Guidelines for bone metabolism and disease in chronic kidney disease) . Am J Kidney Dis . 2003;42:S1–S202
  174. Hines TG , Jacobson NL , Beitz DC , et al.   Dietary calcium and vitamin D. Risk factors in the development of atherosclerosis in young goats . J Nutr . 1985;115:167–178
  175. Teng M , Wolf M , Ofsthun MN , et al.   Activated injectable vitamin D and hemodialysis survival (A historical cohort study) . J Am Soc Nephrol . 2005;16:1115–1125
  176. Kalantar-Zadeh K , Regidor DL , McAllister CJ . Time-varying association between paracalcitol and survival in hemodialysis patients . J Am Soc Nephrol . 2005;16:278A–279A (abstr)
  177. Salonen JT , Nyyssonen K , Korpela H , et al.   High stored iron levels are associated with excess risk of myocardial infarction in eastern Finnish men . Circulation . 1992;86:803–811
  178. Sullivan JL . The iron paradigm of ischemic heart disease . Am Heart J . 1989;117:1177–1188
  179. Sempos CT , Looker AC , Gillum RF , et al.   Body iron stores and the risk of coronary heart disease . N Engl J Med . 1994;330:1119–1124
  180. Taccone-Gallucci M , Di Nucci G , Meloni C , et al.   Risk of iron overload and ‘hemochromatosis allele(s)’ in patients on maintenance hemodialysis . Am J Nephrol . 1987;7:28–32
  181. Kalantar-Zadeh K , Luft FC . Diagnosis of hemochromatosis . Ann Intern Med . 1999;131:311
  182. Zager RA , Johnson AC , Hanson SY , et al.   Parenteral iron formulations (A comparative toxicologic analysis and mechanisms of cell injury) . Am J Kidney Dis . 2002;40:90–103
  183. Weiss G , Meusburger E , Radacher G , et al.   Effect of iron treatment on circulating cytokine levels in ESRD patients receiving recombinant human erythropoietin . Kidney Int . 2003;64:572–578
  184. Pecoits-Filho R , Lindholm B , Stenvinkel P . End-stage renal disease (A state of chronic inflammation and hyperleptinemia) . Eur J Clin Invest . 2003;33:527–528
  185. Don BR , Rosales LM , Levine NW , et al.   Leptin is a negative acute phase protein in chronic hemodialysis patients . Kidney Int . 2001;59:1114–1120
  186. Stenvinkel P , Lindholm B , Lonnqvist F , et al.   Increases in serum leptin levels during peritoneal dialysis are associated with inflammation and a decrease in lean body mass . J Am Soc Nephrol . 2000;11:1303–1309
  187. Odamaki M , Furuya R , Yoneyama T , et al.   Association of the serum leptin concentration with weight loss in chronic hemodialysis patients . Am J Kidney Dis . 1999;33:361–368
  188. Heimburger O , Lonnqvist F , Danielsson A , et al.   Serum immunoreactive leptin concentration and its relation to the body fat content in chronic renal failure . J Am Soc Nephrol . 1997;8:1423–1430
  189. Iglesias P , Diez JJ , Fernandez-Reyes MJ , et al.   Effects of short-term recombinant human growth hormone therapy on plasma leptin concentrations in dialysis patients . Nephrol Dial Transplant . 2002;17:260–264
  190. Fouque D , Juillard L , Lasne Y , et al.   Acute leptin regulation in end-stage renal failure (The role of growth hormone and IGF-1) . Kidney Int . 1998;54:932–937
  191. Aguilera A , Bajo MA , Rebollo F , et al.   Leptin as a marker of nutrition and cardiovascular risk in peritoneal dialysis patients . Adv Perit Dial . 2002;18:212–217
  192. Suliman ME , Barany P , Kalantar-Zadeh K , et al.   Homocysteine in uraemia—a puzzling and conflicting story . Nephrol Dial Transplant . 2005;20:16–21
  193. Lynn KL . Hypertension and survival in hemodialysis patients . Semin Dial . 2004;17:270–274
  194. Agarwal R . Exploring the paradoxical relationship of hypertension with mortality in chronic hemodialysis . Hemodial Int . 2004;8:207–213
  195. Lavie CJ , Mehra MR , Milani RV . Obesity and heart failure prognosis (Paradox or reverse epidemiology?) . Eur Heart J . 2005;26:5–7
  196. Charra B , Chazot C , Jean G , et al.   Reverse epidemiology and hemodialysis blood pressure . Kidney Int . 2003;64:2323–2324
  197. Abbott KC . Reverse epidemiology and obesity in maintenance dialysis patients . Kidney Int . 2003;64:1138
  198. Perna AF , Acanfora F , Satta E , et al.   Hyperhomocysteinemia and cardiovascular disease in uremia (The newest evidence in epidemiology and mechanisms of action) . Semin Nephrol . 2004;24:426–430
  199. Gruberg L , Weissman NJ , Waksman R , et al.   The impact of obesity on the short-term and long-term outcomes after percutaneous coronary intervention (The obesity paradox?) . J Am Coll Cardiol . 2002;39:578–584
  200. Gurm HS , Brennan DM , Booth J , et al.   Impact of body mass index on outcome after percutaneous coronary intervention (the obesity paradox) . Am J Cardiol . 2002;90:42–45
  201. Lavie CJ , Milani RV . Obesity and cardiovascular disease (The Hippocrates paradox?) . J Am Coll Cardiol . 2003;42:677–679
  202. Potapov EV , Loebe M , Anker S , et al.   Impact of body mass index on outcome in patients after coronary artery bypass grafting with and without valve surgery . Eur Heart J . 2003;24:1933–1941
  203. Lew SQ , Cohn F , Cohen LM , et al.   Ethical issues in aging and renal disease . Adv Ren Replace Ther . 2000;7:63–69
  204. Gruberg L , Mercado N , Milo S , et al.   Impact of body mass index on the outcome of patients with multivessel disease randomized to either coronary artery bypass grafting or stenting in the ARTS trial (The obesity paradox II?) . Am J Cardiol . 2005;95:439–444
  205. Grabowski DC , Ellis JE . High body mass index does not predict mortality in older people (Analysis of the Longitudinal Study of Aging) . J Am Geriatr Soc . 2001;49:968–979
  206. Halabi S , Small EJ , Vogelzang NJ . Elevated body mass index predicts for longer overall survival duration in men with metastatic hormone-refractory prostate cancer . J Clin Oncol . 2005;23:2434–2435
  207. Chlebowski RT , Grosvenor M , Lillington L , et al.   Dietary intake and counseling, weight maintenance, and the course of HIV infection . J Am Diet Assoc . 1995;95:428–435
  208. McClellan WM , Chertow GM . Beyond Framingham (Cardiovascular risk profiling in ESRD) . J Am Soc Nephrol . 2005;16:1539–1541
  209. Kalantar-Zadeh K , Anker SD , Coats AJ , et al.   Obesity paradox as a component of reverse epidemiology in heart failure (letter) . Arch Intern Med . 2005;165:1797
  210. Mortality patterns—United States, 1997 . MMWR Morb Mortal Wkly Rep . 1999;48:664–668
  211. Asher CR , Topol EJ , Moliterno DJ . Insights into the pathophysiology of atherosclerosis and prognosis of black Americans with acute coronary syndromes . Am Heart J . 1999;138:1073–1081
  212. Davey Smith G , Neaton JD , Wentworth D , et al.   Mortality differences between black and white men in the USA: Contribution of income and other risk factors among men screened for the MRFIT. MRFIT Research Group. Multiple Risk Factor Intervention Trial . Lancet . 1998;351:934–939
  213. Unruh M , Miskulin D , Yan G , et al.   Racial differences in health-related quality of life among hemodialysis patients . Kidney Int . 2004;65:1482–1491
  214. Kutner NG , Zhang R , Brogan D . Race, gender, and incident dialysis patients’ reported health status and quality of life . J Am Soc Nephrol . 2005;16:1440–1448
  215. Reddan DN , Szczech LA , Klassen PS , et al.   Racial inequity in America’s ESRD program . Semin Dial . 2000;13:399–403
  216. Sehgal AR . Impact of quality improvement efforts on race and sex disparities in hemodialysis . JAMA . 2003;289:996–1000
  217. Alexander GC , Sehgal AR . Barriers to cadaveric renal transplantation among blacks, women, and the poor . JAMA . 1998;280:1148–1152
  218. Kutner NG , Zhang R . Body mass index as a predictor of continued survival in older chronic dialysis patients . Int Urol Nephrol . 2001;32:441–448
  219. Wong JS , Port FK , Hulbert-Shearon TE , et al.   Survival advantage in Asian American end-stage renal disease patients . Kidney Int . 1999;55:2515–2523
  220. Zimmerer JL , Leon JB , Covinsky KE , et al.   Diet monotony as a correlate of poor nutritional intake among hemodialysis patients . J Ren Nutr . 2003;13:72–77
  221. Ling PR , Smith RJ , Kie S , et al.   Effects of protein malnutrition on IL-6-mediated signaling in the liver and the systemic acute-phase response in rats . Am J Physiol . 2004;287:R801–R808
  222. Kalantar-Zadeh K , Kopple JD , Deepak S , et al.   Food intake characteristics of hemodialysis patients as obtained by food frequency questionnaire . J Ren Nutr . 2002;12:17–31
  223. Fanti P , Stephenson TJ , Kaariainen IM , et al.   Serum isoflavones and soya food intake in Japanese, Thai and American end-stage renal disease patients on chronic haemodialysis . Nephrol Dial Transplant . 2003;18:1862–1868
  224. Fanti P , Sawaya BP , Custer LJ , et al.   Serum levels and metabolic clearance of the isoflavones genistein and daidzein in hemodialysis patients . J Am Soc Nephrol . 1999;10:864–871
  225. Canada-USA Peritoneal Dialysis Study Group . Adequacy of dialysis and nutrition in continuous peritoneal dialysis (Association with clinical outcomes) . J Am Soc Nephrol . 1996;7:198–207
  226. Hakim RM , Lowrie E . Obesity and mortality in ESRD (Is it good to be fat?) . Kidney Int . 1999;55:1580–1581
  227. McCusker FX , Teehan BP , Thorpe KE , et al.  Canada-USA (CANUSA) Peritoneal Dialysis Study Group   How much peritoneal dialysis is necessary for maintaining a good nutritional status? . Kidney Int Suppl . 1996;56:S56–S61
  228. Johnson DW , Herzig KA , Purdie DM , et al.   Is obesity a favorable prognostic factor in peritoneal dialysis patients? . Perit Dial Int . 2000;20:715–721
  229. Chung SH , Lindholm B , Lee HB . Influence of initial nutritional status on continuous ambulatory peritoneal dialysis patient survival . Perit Dial Int . 2000;20:19–26
  230. Snyder JJ , Foley RN , Gilbertson DT , et al.   Body size and outcomes on peritoneal dialysis in the United States . Kidney Int . 2003;64:1838–1844
  231. McDonald SP , Collins JF , Johnson DW . Obesity is associated with worse peritoneal dialysis outcomes in the Australia and New Zealand patient populations . J Am Soc Nephrol . 2003;14:2894–2901
  232. Abbott KC , Glanton CW , Trespalacios FC , et al.   Body mass index, dialysis modality, and survival (Analysis of the United States Renal Data System Dialysis Morbidity and Mortality Wave II Study) . Kidney Int . 2004;65:597–605
  233. Aslam N , Bernardini J , Fried L , et al.   Large body mass index does not predict short-term survival in peritoneal dialysis patients . Perit Dial Int . 2002;22:191–196
  234. Shlipak MG , Fried LF , Cushman M , et al.   Cardiovascular mortality risk in chronic kidney disease (comparison of traditional and novel risk factors) . JAMA . 2005;293:1737–1745
  235. Kovesdy CP , Trivedi BK , Anderson JE , et al.   Atherosclerotic cardiovascular disease explains the inverse association between blood pressure and mortality in patients with chronic kidney disease not yet on dialysis . J Am Soc Nephrol . 2005;16:335A; (abstr)
  236. Pelletier SJ , Maraschio MA , Schaubel DE , et al.   Survival benefit of kidney and liver transplantation for obese patients on the waiting list . Clin Transpl . 2003;1:77–88
  237. Friedman AN , Miskulin DC , Rosenberg IH , et al.   Demographics and trends in overweight and obesity in patients at time of kidney transplantation . Am J Kidney Dis . 2003;41:480–487
  238. Meier-Kriesche HU , Vaghela M , Thambuganipalle R , et al.   The effect of body mass index on long-term renal allograft survival . Transplantation . 1999;68:1294–1297
  239. Meier-Kriesche HU , Arndorfer JA , Kaplan B . The impact of body mass index on renal transplant outcomes (A significant independent risk factor for graft failure and patient death) . Transplantation . 2002;73:70–74
  240. Halme L , Eklund B , Kyllonen L , et al.   Is obesity still a risk factor in renal transplantation? . Transpl Int . 1997;10:284–288
  241. Feldman HI , Fazio I , Roth D , et al.   Recipient body size and cadaveric renal allograft survival . J Am Soc Nephrol . 1996;7:151–157
  242. Pischon T , Sharma AM . Obesity as a risk factor in renal transplant patients . Nephrol Dial Transplant . 2001;16:14–17
  243. Drafts HH , Anjum MR , Wynn JJ , et al.   The impact of pre-transplant obesity on renal transplant outcomes . Clin Transplant . 1997;11:493–496
  244. Modlin CS , Flechner SM , Goormastic M , et al.   Should obese patients lose weight before receiving a kidney transplant? . Transplantation . 1997;64:599–604
  245. Keith DS , Nichols GA , Gullion CM , et al.   Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization . Arch Intern Med . 2004;164:659–663
  246. Menon V , Sarnak M , Greene T , et al.   Homocysteine as a predictor of all-cause and cardiovascular mortality in chronic kidney disease . J Am Soc Nephrol . 2005; (abstr) (in press)

PII: S0270-9295(05)00186-5

doi: 10.1016/j.semnephrol.2005.09.005

Seminars in Nephrology
Volume 26, Issue 2 , Pages 118-133 , March 2006

Article Tools

* Image Usage & Resolution